(Q48930408)

16 February 2018

title

The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. (English)

1 reference

16 February 2018

author name string

T Paslawski

1

1 reference

16 February 2018

D Treit

2

1 reference

16 February 2018

G B Baker

3

1 reference

16 February 2018

M George

4

1 reference

16 February 2018

R T Coutts

5

1 reference

16 February 2018

publication date

1 September 1996

1 reference

16 February 2018

number of pages

6

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

16 February 2018

volume

127

1 reference

16 February 2018

issue

1

1 reference

16 February 2018

page(s)

19-24

1 reference

16 February 2018

Effects of the antidepressant phenelzine on brain levels of γ-aminobutyric acid (GABA)

cites work

1 reference

12 December 2020

Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid?

1 reference

12 December 2020

The effects of selective and non-selective monoamine oxidase (MAO) inhibitors on conflict behavior in the rat

1 reference

12 December 2020

The GABA-ergic system: a locus of benzodiazepine action

1 reference

12 December 2020

Animal models for the study of anti-anxiety agents: a review

1 reference

12 December 2020

Two tests in rats for antianxiety effect of clinically anxiety attenuating antidepressants.

1 reference

12 December 2020

Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat.

1 reference

12 December 2020

Tricyclic antidepressants in the treatment of panic and anxiety disorders.

1 reference

12 December 2020

Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze.

1 reference

12 December 2020

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

12 December 2020

Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

1 reference

12 December 2020

The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines.

1 reference

12 December 2020

GABAmimetic agents display anxiolytic-like effects in the social interaction and elevated plus maze procedures

1 reference

12 December 2020

The contribution of behavioural studies to the neuropharmacology of anxiety

1 reference

12 December 2020

Exploration of mice in a black and white test box: validation as a model of anxiety.

1 reference

12 December 2020

Synthesis and pharmacological evaluation of acyl derivatives of phenelzine

1 reference

12 December 2020

Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat.

1 reference

12 December 2020

Vigabatrin has an anxiolytic effect in the elevated plus-maze test of anxiety

1 reference

12 December 2020

Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines

1 reference

12 December 2020

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

1 reference

12 December 2020

In vitro and in vivo inhibition by benserazide of clorgyline-resistant amine oxidases in rat cardiovascular tissues

1 reference

12 December 2020

Conditioned defensive burying: A new paradigm for the study of anxiolytic agents

1 reference

12 December 2020

Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function

1 reference

12 December 2020

Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective

1 reference

12 December 2020

Ultrasonic vocalization in response to unavoidable aversive stimuli in rats: effects of benzodiazepines.

1 reference

12 December 2020

Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia

1 reference

12 December 2020

Studies in vivo and in vitro on N-acetylphenelzine

1 reference

12 December 2020

Antipanic drug treatments: failure to exhibit anxiolytic-like effects on defensive burying behavior.

1 reference

12 December 2020

Effects of acute and chronic administration of the antidepressants, imipramine, phenelzine and mianserin, on the social behaviour of mice

1 reference

12 December 2020

Chronic treatment with imipramine does not reverse the effects of 3 anxiogenic compounds in a test of anxiety in the rat.

1 reference

12 December 2020

Amino acid neurotransmitters and dopamine in brain and pituitary of the goldfish: involvement in the regulation of gonadotropin secretion

1 reference

12 December 2020

Ethologically-based animal models of anxiety disorders

1 reference

12 December 2020

Fear-enhanced acoustic startle is not attenuated by acute or chronic imipramine treatment in rats.

1 reference

12 December 2020

Profiles of the antipanic compounds, triazolobenzodiazepines and phenelzine, in two animal tests of anxiety.

1 reference

12 December 2020

Insights into the structure and function of GABA-benzodiazepine receptors: ion channels and psychiatry

1 reference

12 December 2020

N2-acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines.

1 reference

12 December 2020

Identifiers

0 references

1 reference

16 February 2018